Table 1 The demographic and clinical parameters of patients with TB and DM
From: Risk factors for multidrug resistance in tuberculosis patients with diabetes mellitus
Non-MDR TB with DM (n = 156) | MDR TB with DM (n = 44) | P value | |
|---|---|---|---|
Male, n (%) | 127 (0.81) | 35 (0.79) | 0.781 |
Age < 65 years old, n (%) | 88 (0.56) | 36 (0.81) | 0.002 |
Body mass index (BMI) | 21.33 ± 3.60 | 21.11 ± 3.66 | 0.720 |
Smoking history, n (%) | 55 (0.35) | 23 (0.52) | 0.041 |
History of alcoholism, n (%) | 21 ( (0.13) | 9 (0.20) | 0.251 |
History of TB treatment, n (%) | 18 (0.11) | 26 (0.59) | 0.001 |
DM duration (month) | 44.87 ± 17.91 | 56.72 ± 16.85 | 0.544 |
Coronary heart disease, n (%) | 14 (0.08) | 5 (0.11) | 0.633 |
Chronic obstructive pulmonary disease, n (%) | 16 (0.10) | 3 (0.06) | 0.492 |
Hypertension, n (%) | 38 (0.24) | 8 (0.18) | 0.390 |
Cerebral infarction, n (%) | 20 (0.13) | 7 (0.16) | 0.596 |
HIV,n (%) | 7 (0.04) | 3 (0.07) | 0.531 |
Treatment of diabetes (insulin), n (%) | 43 (0.27) | 10 (0.23) | 0.521 |
Empty hole, n (%) | 124 (0.79) | 39 (0.88) | 0.167 |
With pleural effusion, n (%) | 39 (0.25) | 12 (0.27) | 0.760 |
HbA1c, % | 8.94 ± 2.45 | 11.12 ± 2.46 | 0.001 |
Erythrocyte sedimentation rate, mm/h | 41.87 ± 26.03 | 43.62 ± 20.58 | 0.725 |
Hypersensitive C-reactive protein, ng/L | 47.61 ± 37.28 | 36.14 ± 27.15 | 0.470 |
White blood cell count, 109 | 7.33 ± 2.91 | 7.01 ± 2.39 | 0.508 |
Neutrophil count, 109 | 5.37 ± 2.72 | 4.98 ± 2.21 | 0.377 |
Lymphocyte count | 1.21 ± 0.566 | 1.28 ± 0.54 | 0.445 |
Haemoglobin, g/L | 117.01 ± 20.57 | 120.79 ± 18.84 | 0.273 |
Platelet, 109 | 302.32 ± 120.54 | 299.16 ± 102.01 | 0.874 |
ALT, U/L | 21.69 ± 19.61 | 20.25 ± 12.50 | 0.678 |
AST, U/L | 25.93 ± 13.94 | 26.38 ± 17.23 | 0.920 |
Albumin, g/L | 32.90 ± 6.18 | 33.88 ± 6.05 | 0.350 |
Uric acid, umol/L | 277.91 ± 127.43 | 324.55 ± 144.27 | 0.059 |
Creatinine, umol/L | 64.23 ± 51.17 | 60.72 ± 26.04 | 0.662 |